Hyphens Pharma International Limited (1J5)
Financial Statements and Related Announcement: Half Yearly Results (2026)
Financial Statements and Related Announcement: Half Yearly Results (2026)
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
Change - Announcement of Cessation: Cessation of Group Chief Operating Officer
Change - Announcement of Appointment: Appointment of Group Chief Operating Officer
General Announcement: Appointment of Group Chief Operating Officer
Charlotte's Web Reports Second Quarter 2026 Financial Results
General Announcement: Entry into (i) MOU with PILA and (ii) LOI with KORIKA; and Appointment of New Senior Leadership
Financial Statements and Related Announcement: Half Yearly Results
13D/A1-RECANATI LEON
Lufax to Announce Second Quarter 2026 Financial Results on August 18, 2026